Julia Möllmann

1.2k total citations
22 papers, 831 citations indexed

About

Julia Möllmann is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Julia Möllmann has authored 22 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Julia Möllmann's work include Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Julia Möllmann is often cited by papers focused on Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Julia Möllmann collaborates with scholars based in Germany, Netherlands and Italy. Julia Möllmann's co-authors include Michael Lehrke, Nikolaus Marx, Corinna Lebherz, Florian Kahles, Frank Tacke, Christian Trautwein, Alexander Koch, Matthias Rau, C. Meyer and Hannes M. Findeisen and has published in prestigious journals such as Nature Communications, Diabetes and Scientific Reports.

In The Last Decade

Julia Möllmann

21 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Möllmann Germany	16	382	294	194	179	122	22	831
Maria Grazia Zenti Italy	12	225 0.6×	139 0.5×	190 1.0×	95 0.5×	143 1.2×	26	680
Harshini Mudaliar Australia	8	286 0.7×	209 0.7×	147 0.8×	116 0.6×	54 0.4×	9	671
Moufida Ben Nasr United States	19	479 1.3×	293 1.0×	485 2.5×	220 1.2×	50 0.4×	38	1.2k
Subhashini Yaturu United States	15	313 0.8×	289 1.0×	171 0.9×	58 0.3×	81 0.7×	34	976
W. Reid Litchfield United States	14	490 1.3×	185 0.6×	273 1.4×	224 1.3×	207 1.7×	18	946
Yuya Tsurutani Japan	15	254 0.7×	245 0.8×	211 1.1×	69 0.4×	63 0.5×	54	700
Jaime Ibarrola Spain	18	135 0.4×	250 0.9×	184 0.9×	256 1.4×	260 2.1×	30	772
Keiichi Torimoto Japan	14	441 1.2×	163 0.6×	167 0.9×	70 0.4×	149 1.2×	58	777
Yukihiro Nagai Japan	15	208 0.5×	229 0.8×	219 1.1×	85 0.5×	68 0.6×	49	812
Jiandong Zhang China	14	192 0.5×	132 0.4×	82 0.4×	134 0.7×	156 1.3×	22	651

Countries citing papers authored by Julia Möllmann

Since Specialization

Citations

This map shows the geographic impact of Julia Möllmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Möllmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Möllmann more than expected).

Fields of papers citing papers by Julia Möllmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Möllmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Möllmann. The network helps show where Julia Möllmann may publish in the future.

Co-authorship network of co-authors of Julia Möllmann

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Möllmann. A scholar is included among the top collaborators of Julia Möllmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Möllmann. Julia Möllmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Möllmann, Julia, Barbara M. Klinkhammer, Heidi Noels, et al.. (2025). Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling Pathway. The FASEB Journal. 39(10). e70639–e70639.

Miguel, Verónica, Katharina C. Reimer, Jitske Jansen, et al.. (2023). Protocol to analyze bioenergetics in single human induced-pluripotent-stem-cell-derived kidney organoids using Seahorse XF96. STAR Protocols. 4(1). 101999–101999. 2 indexed citations

Thiele, Kirsten, Matthias Rau, Niels‐Ulrik Korbinian Hartmann, et al.. (2022). Empagliflozin Reduces Markers of Acute Kidney Injury in Patients with Acute Decompensated Heart Failure. ESC Heart Failure. 9(4). 2233–2238. 24 indexed citations

Rau, Matthias, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, et al.. (2022). Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study. Bone Reports. 16. 101175–101175. 19 indexed citations

Rau, Matthias, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, et al.. (2021). Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study. Atherosclerosis. 330. 8–13. 11 indexed citations

Rau, Matthias, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, et al.. (2021). Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study. Cardiovascular Diabetology. 20(1). 6–6. 46 indexed citations

Dreschers, Stephan, Kim Ohl, Julia Möllmann, Klaus Tenbrock, & Thorsten Orlikowsky. (2021). Leucine Reconstitutes Phagocytosis-Induced Cell Death in E. coli-Infected Neonatal Monocytes—Effects on Energy Metabolism and mTOR Signaling. International Journal of Molecular Sciences. 22(8). 4271–4271. 5 indexed citations

Dreschers, Stephan, Kim Ohl, Michael Lehrke, et al.. (2019). Impaired cellular energy metabolism in cord blood macrophages contributes to abortive response toward inflammatory threats. Nature Communications. 10(1). 1685–1685. 47 indexed citations

Kahles, Florian, Ana C. Liberman, Matthias Rau, et al.. (2018). The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation. Molecular Metabolism. 14. 150–157. 51 indexed citations

10.

Ohl, Kim, Athanassios Fragoulis, Julian Baumeister, et al.. (2018). Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis. Frontiers in Immunology. 9. 1552–1552. 46 indexed citations

11.

Vajen, Tanja, Rory R. Koenen, Delia Projahn, et al.. (2018). Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis. Scientific Reports. 8(1). 10647–10647. 66 indexed citations

12.

Soppert, Josefin, Sandra Kraemer, Christian Beckers, et al.. (2018). Soluble CD74 Reroutes MIF/CXCR4/AKT‐Mediated Survival of Cardiac Myofibroblasts to Necroptosis. Journal of the American Heart Association. 7(17). e009384–e009384. 48 indexed citations

13.

Zhu, Mengyu, Yuanyuan Wei, Claudia Geißler, et al.. (2017). Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by TargetingMafb. Diabetes. 66(12). 3072–3084. 46 indexed citations

14.

Lebherz, Corinna, Georg Schlieper, Julia Möllmann, et al.. (2017). GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease. The American Journal of Medicine. 130(7). 833–841.e3. 53 indexed citations

15.

Kahles, Florian, C. Meyer, Sandra S. Diebold, et al.. (2016). Glucose‐dependent insulinotropic peptide secretion is induced by inflammatory stimuli in an interleukin‐1‐dependent manner in mice. Diabetes Obesity and Metabolism. 18(11). 1147–1151. 22 indexed citations

16.

Möllmann, Julia, Florian Kahles, Corinna Lebherz, et al.. (2016). The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism. Diabetes Obesity and Metabolism. 19(4). 496–508. 37 indexed citations

17.

Stöhr, Robert, Maria Mavilio, Arianna Marino, et al.. (2015). ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice. Scientific Reports. 5(1). 9023–9023. 38 indexed citations

18.

Kahles, Florian, Julia Möllmann, Ana C. Liberman, et al.. (2014). The PDE-4 Inhibitor Roflumilast reduces weight gain, enhances insulin sensitivity and prevents hepatic steatosis in mice by increasing mitochondrogenesis. Diabetologie und Stoffwechsel. 9(S 01). 1 indexed citations

19.

Burgmaier, Mathias, Ana C. Liberman, Julia Möllmann, et al.. (2013). Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe−/− mice. Atherosclerosis. 231(2). 427–435. 62 indexed citations

20.

Möllmann, Julia, et al.. (2013). Mortality reduction with IABP prior to CABG in emergency patients with shock. The Thoracic and Cardiovascular Surgeon. 61(S 01). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact